Emerging strategies in neoadjuvant therapy for non-small cell lung cancer: Progress and future directions
Cancer Pathogenesis and Therapy · 2025-11 · 3 (6) · 451-452
DOI: 10.1016/j.cpt.2024.08.004 ↗Kurz gefasst
Editorial in der Zeitschrift Cancer Pathogenesis and Therapy, 2025-11. Verfasst von Ying Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, …. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Table 1 Key clinical trials of perioperative immunotherapy in resectable non-small cell lung cancer.Clinical trial Treatment mode Immunotherapy modalities Did not undergo surgery (%) R0 resection (%) pCR (%) MPR (%)
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong 250000, China.
- National Institutes for Food and Drug Control, Beijing 102629, China.
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, and Shandong Academy of Medical Sciences, Jinan, Shandong 250000, China.
- Department of Medical Oncology, Shandong Cancer Hospital and Institute, Affiliated Hospital of Weifang Medical University, School of Clinical Medicine, Weifang Medical University, Weifang, Shandong 261000, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
Zitieren
APA
Li, Y., Wang, Y., Zhao, J., Li, R., Dong, X., Yao, X., An, H., Chen, W., & Li, Y. (2025). Emerging strategies in neoadjuvant therapy for non-small cell lung cancer: Progress and future directions. Cancer Pathogenesis and Therapy, 3(6), 451-452. https://doi.org/10.1016/j.cpt.2024.08.004
Vancouver
Li Y, Wang Y, Zhao J, Li R, Dong X, Yao X, et al. Emerging strategies in neoadjuvant therapy for non-small cell lung cancer: Progress and future directions. Cancer Pathogenesis and Therapy. 2025;3(6):451-452. doi:10.1016/j.cpt.2024.08.004
BibTeX
@article{Li2025,
author = {Li, Ying and Wang, Yue and Zhao, Junfeng and Li, Ruyue and Dong, Xue and Yao, Xiujing and An, Hao and Chen, Wenjie and Li, Yintao},
title = {Emerging strategies in neoadjuvant therapy for non-small cell lung cancer: Progress and future directions},
journal = {Cancer Pathogenesis and Therapy},
year = {2025},
volume = {3},
number = {6},
pages = {451--452},
doi = {10.1016/j.cpt.2024.08.004}
}
EUVIMED